Michael B. Jebsen
2016
In 2016, Michael B. Jebsen earned a total compensation of $704.4K as President, Interim Chief Executive Officer and Chief Financial Officer at Tenax Therapeutics, a 66% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,250 |
|---|---|
| Option Awards | $233,168 |
| Salary | $325,000 |
| Total | $704,418 |
Jebsen received $325K in salary, accounting for 46% of the total pay in 2016.
Jebsen also received $146.3K in non-equity incentive plan and $233.2K in option awards.
Rankings
In 2016, Michael B. Jebsen's compensation ranked 9,847th out of 14,075 executives tracked by ExecPay. In other words, Jebsen earned more than 30.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,847 out of 14,075 | 30th |
Division Manufacturing | 3,805 out of 5,486 | 31st |
Major group Chemicals And Allied Products | 1,332 out of 1,900 | 30th |
Industry group Drugs | 1,060 out of 1,543 | 31st |
Industry Pharmaceutical Preparations | 832 out of 1,173 | 29th |
Source: SEC filing on April 20, 2018.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2016.
2016
John Kelley
Tenax Therapeutics